HSIC · Henry Schein Inc
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Medical Distribution — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HSIC
this stock
Henry Schein Inc
|
$9.48B | +12.5% | +5.9% | 24.8 | 7.3% |
|
MCK
Mckesson Corp
|
$106.21B | +7.2% | +3.1% | 24.4 | 2.4% |
|
COR
Cencora, Inc.
|
$61.09B | -8.4% | +9.3% | 23.8 | 2.4% |
|
CAH
Cardinal Health Inc
|
$54.51B | +10.1% | +14.2% | — | 2.9% |
|
EBOSY
EBOS Group Limited/ADR
|
$2.34B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HSIC | -2.6% | -4.8% | +15.4% | -5.3% | +12.5% |
| SPY | +0.6% | -0.8% | +18.2% | -0.6% | +11.8% |
| vs SPY | -3.2% | -3.9% | -2.9% | -4.7% | +0.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.